← Leaderboards
Qizhen Shi
Medical College Of Wisconsin
$6,437,223
Attributed
$6,437,223
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $579.3K · FY2010–25$1M$750K$500K$250K$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$6,437,223 · 1
By mechanism
R01$6,437,223 · 1
Top collaborators
No co-investigators on record.
Most similar at Medical College Of Wisconsin
Same institution · by research overlap
- Robert R Montgomery$28,575,312
- David Allen Wilcox$6,145,617
- Parameswaran N Hari$2,110,213
- David P Lillicrap$6,013,971
- Mary Eapen$20,614,610
Others in their field
Top investigators on “Regimen”
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$437,810,708
- Dennis R. Burton · Scripps Research Institute$277,571,345
- Barton F Haynes · Duke University$225,091,182
- Lawrence Corey · Fred Hutchinson Cancer Center$213,218,824
- Peter B. Gilbert · Fred Hutchinson Cancer Center$192,864,303
- Carol Nesel · Westat$157,229,158
Research focus
RegimenProtocols DocumentationInjuryProductionNovel StrategiesProteinsFactor ViiiImmunityImmune ResponseHemostatic FunctionGene DeliveryHemophilia AHematopoietic Stem CellsCellsClinical TrialsCarrier ProteinsAntibodiesGene TherapyHemorrhageGenerationsComplicationBlood PlateletsAffectSafety
Grant awards (15)
Platelet-derived FVIII Gene Therapy of Hemophilia A$572,808
R01 · FY2025 · HL · contact PI
Platelet-derived FVIII Gene Therapy of Hemophilia A$579,308
R01 · FY2024 · HL · contact PI
Platelet-derived FVIII Gene Therapy of Hemophilia A$513,937
R01 · FY2022 · HL · contact PI
Platelet-derived FVIII Gene Therapy of Hemophilia A$508,795
R01 · FY2021 · HL · contact PI
Platelet-derived FVIII Gene Therapy of Hemophilia A$503,805
R01 · FY2020 · HL · contact PI
Platelet-derived FVIII Gene Therapy of Hemophilia A$505,458
R01 · FY2019 · HL · contact PI
Platelet-derived FVIII Gene Therapy of Hemophilia A$366,156
R01 · FY2018 · HL · contact PI
Platelet-derived FVIII Gene Therapy of Hemophilia A$367,344
R01 · FY2017 · HL · contact PI
Platelet-derived FVIII Gene Therapy of Hemophilia A$368,509
R01 · FY2016 · HL · contact PI
Platelet-derived FVIII Gene Therapy of Hemophilia A$376,105
R01 · FY2015 · HL · contact PI
Platelet-Derived FVIII Gene Therapy of Hemophilia A$346,457
R01 · FY2014 · HL · contact PI
Platelet-Derived FVIII Gene Therapy of Hemophilia A$337,564
R01 · FY2013 · HL · contact PI
Platelet-Derived FVIII Gene Therapy of Hemophilia A$355,610
R01 · FY2012 · HL · contact PI
Platelet-Derived FVIII Gene Therapy of Hemophilia A$360,207
R01 · FY2011 · HL · contact PI
Platelet-Derived FVIII Gene Therapy of Hemophilia A$375,160
R01 · FY2010 · HL · contact PI